Last 12 months
Inside the activity.
1 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 11, 2026 18:02 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 206 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-005931 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,951 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 18:02 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 206 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-005930 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,575 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 14:43 UTC |
Jarkowski Hope M.Chief Legal Officer
|
SaleCommon Stock | 1,966 | $155.00 | $304,720.17 |
DisclosureSEC source: 0001225208-26-005815 · doc4.xml · nonDerivative · entry 1 Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.25 Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 18:24 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 127 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004467 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,942 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 18:24 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 16 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004468 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,676 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 18:24 UTC |
keller brettDirector
|
GrantCommon Stock | 26 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004469 · doc4.xml · nonDerivative · entry 2 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,968 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 18:24 UTC |
keller brettDirector
|
GrantCommon Stock | 54 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004469 · doc4.xml · nonDerivative · entry 1 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,942 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 18:24 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004472 · doc4.xml · nonDerivative · entry 2 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,275 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 18:24 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 16 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004472 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,262 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 18:24 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 24 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004474 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,745 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 18:24 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 27 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004474 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,721 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 18:24 UTC |
Mosconi Patricia AnnDirector
|
GrantCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004471 · doc4.xml · nonDerivative · entry 1 Mosconi Patricia Ann · CIK 0002111349 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 432 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 18:24 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 16 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004473 · doc4.xml · nonDerivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,369 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 18:24 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004473 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,353 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 18:24 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 29 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004470 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,345.102 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 18:24 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 87 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004470 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,316.102 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 07, 2026 Filed Apr 8, 2026 18:00 UTC |
keller brettDirector
|
GrantCommon Stock | 177 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004441 · doc4.xml · nonDerivative · entry 1 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,888 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 07, 2026 Filed Apr 8, 2026 18:00 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 384 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004442 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,246 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 07, 2026 Filed Apr 8, 2026 18:00 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 177 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004443 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,336 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 07, 2026 Filed Apr 8, 2026 18:00 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 206 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004445 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,229.102 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 07, 2026 Filed Apr 8, 2026 18:00 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 177 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004444 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,694 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:10 UTC |
Jarkowski Hope M.Chief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,879 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004190 · doc4.xml · derivative · entry 3 Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,879 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2026 2879 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2026 2879 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2026 2879 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2026 2879 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:10 UTC |
Jarkowski Hope M.Chief Legal Officer
|
Tax withholdingCommon Stock | 913 | $159.98 | $146,061.74 |
DisclosureSEC source: 0001225208-26-004190 · doc4.xml · nonDerivative · entry 2 Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,967.25 Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:10 UTC |
Jarkowski Hope M.Chief Legal Officer
|
Exercise / conversionCommon Stock | 2,879 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004190 · doc4.xml · nonDerivative · entry 1 Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,880.25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2026 2879 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| March 27, 2026 Filed Aug 11, 2026 16:41 UTC |
Markus Maura A.Director
|
OtherCommon Stock | 60 | $157.28 | $9,436.80 |
DisclosureSEC source: 0001225208-26-007055 · doc5.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,083.102 Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 23:40 UTC |
Gokey Timothy CDirector · CEO
|
PurchaseCommon Stock | 5,300 | $194.49 | $1,030,794.35 |
DisclosureSEC source: 0001225208-26-003435 · doc4.xml · nonDerivative · entry 1 Gokey Timothy C · CIK 0001296187 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,876.0271 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in accordance with SEC Rule 10b-18 at prices ranging from $194.1300 - $195.1900, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 18:39 UTC |
Ghei AshimaInterim CFO
|
GrantStock Option (Right to Buy) · Derivative | 23,254 | $0.00 Strike: $190.89 | $0.00 |
DisclosureSEC source: 0001225208-26-003370 · doc4.xml · derivative · entry 1 Ghei Ashima · CIK 0002028322 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,254 Underlying: Common Stock · 23,254 shares Expires 2036-03-05 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning March 5, 2027. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 18:39 UTC |
Jarkowski Hope M.Chief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 20,872 | $0.00 Strike: $190.89 | $0.00 |
DisclosureSEC source: 0001225208-26-003372 · doc4.xml · derivative · entry 1 Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,872 Underlying: Common Stock · 20,872 shares Expires 2036-03-05 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning March 5, 2027. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 18:39 UTC | GrantStock Option (Right to Buy) · Derivative | 170,667 | $0.00 Strike: $190.89 | $0.00 |
DisclosureSEC source: 0001225208-26-003371 · doc4.xml · derivative · entry 1 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,667 Underlying: Common Stock · 170,667 shares Expires 2036-03-05 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning March 5, 2027. Read SEC document |
|
| March 05, 2026 Filed Mar 6, 2026 18:39 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
GrantStock Option (Right to Buy) · Derivative | 10,039 | $0.00 Strike: $190.89 | $0.00 |
DisclosureSEC source: 0001225208-26-003374 · doc4.xml · derivative · entry 1 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,039 Underlying: Common Stock · 10,039 shares Expires 2036-03-05 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning March 5, 2027. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 18:39 UTC |
PERRY CHRISTOPHER JOHNDirector · President
|
GrantStock Option (Right to Buy) · Derivative | 51,047 | $0.00 Strike: $190.89 | $0.00 |
DisclosureSEC source: 0001225208-26-003373 · doc4.xml · derivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,047 Underlying: Common Stock · 51,047 shares Expires 2036-03-05 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning March 5, 2027. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 18:39 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
GrantStock Option (Right to Buy) · Derivative | 25,977 | $0.00 Strike: $190.89 | $0.00 |
DisclosureSEC source: 0001225208-26-003369 · doc4.xml · derivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,977 Underlying: Common Stock · 25,977 shares Expires 2036-03-05 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning March 5, 2027. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 18:39 UTC |
Carey Thomas PCorporate VP
|
GrantStock Option (Right to Buy) · Derivative | 25,977 | $0.00 Strike: $190.89 | $0.00 |
DisclosureSEC source: 0001225208-26-003368 · doc4.xml · derivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,977 Underlying: Common Stock · 25,977 shares Expires 2036-03-05 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning March 5, 2027. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 18:39 UTC |
Mosconi Patricia AnnDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,786 | $0.00 Strike: $190.89 | $0.00 |
DisclosureSEC source: 0001225208-26-003367 · doc4.xml · derivative · entry 2 Mosconi Patricia Ann · CIK 0002111349 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,786 Underlying: Common Stock · 1,786 shares Expires 2036-03-05 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 18:39 UTC |
Mosconi Patricia AnnDirector
|
GrantCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-003367 · doc4.xml · nonDerivative · entry 1 Mosconi Patricia Ann · CIK 0002111349 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 18:43 UTC |
Duelks Robert NDirector
|
GiftCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002929 · doc4.xml · nonDerivative · entry 2 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Mary E. Duelks 2020 Irrevocable Trust Disclosed balance after: 17,000 F1 · shares: This transaction represents the transfer of shares from the Mary E. Duelks 2007 Revocable Trust to the Mary E. Duelks 2020 Irrevocable Trust. F1 · price: This transaction represents the transfer of shares from the Mary E. Duelks 2007 Revocable Trust to the Mary E. Duelks 2020 Irrevocable Trust. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 18:43 UTC |
Duelks Robert NDirector
|
GiftCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002929 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Mary E. Duelks 2007 Revocable Trust Disclosed balance after: 0 F1 · shares: This transaction represents the transfer of shares from the Mary E. Duelks 2007 Revocable Trust to the Mary E. Duelks 2020 Irrevocable Trust. F1 · price: This transaction represents the transfer of shares from the Mary E. Duelks 2007 Revocable Trust to the Mary E. Duelks 2020 Irrevocable Trust. Read SEC document |
| February 25, 2026 Filed Feb 25, 2026 22:15 UTC |
Duelks Robert NDirector
|
Disposition to issuerCommon Stock | 486 | $177.04 | $86,039.01 |
DisclosureSEC source: 0001225208-26-002641 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · BOMAR II LLC Disclosed balance after: 4,474 Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 17:33 UTC |
Duelks Robert NDirector
|
SaleCommon Stock | 253 | $192.60 | $48,727.80 |
DisclosureSEC source: 0001225208-26-001417 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,815 Read SEC document |
| February 06, 2026 Filed Aug 10, 2026 13:47 UTC Amendment |
Duelks Robert NDirector
|
SaleCommon Stock | 253 | $192.60 | $48,727.80 |
DisclosureSEC source: 0001225208-26-007037 · doc4a.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Robert N. Duelks 2007 Revocable Trust Disclosed balance after: 8,600 Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 16:51 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 91 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000316 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,068 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 16:51 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000317 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,660 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 16:51 UTC |
keller brettDirector
|
GrantCommon Stock | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000318 · doc4.xml · nonDerivative · entry 2 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,711 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 16:51 UTC |
keller brettDirector
|
GrantCommon Stock | 39 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000318 · doc4.xml · nonDerivative · entry 1 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,693 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 16:51 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000320 · doc4.xml · nonDerivative · entry 2 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,862 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 16:51 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000320 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,853 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 16:51 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000322 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,517 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 16:51 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 19 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000322 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 16:51 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000321 · doc4.xml · nonDerivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,159 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 16:51 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000321 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,148 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.